Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01488721 · ClinicalTrials.gov registry record

Clinical Evaluation of NeoPlex4 Assay and NeoPlex System

A clinical trial, sponsored by Luminex Corporation.

Completed
Registry status
7,462
Enrollment target

NCT01488721 is a clinical trial that has completed, run by Luminex Corporation. The registered enrollment target is 7,462 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01488721 has completed, sponsored by Luminex Corporation.

COMPLETED
Registry status
7,462 participants
Enrollment target

Study Summary

The purpose of this study is to assess the agreement of clinical performance between the proposed NeoPlex 4 assay and NeoPlex System and the comparator devices in clinical use in newborn screening programs for detection of T4, TSH, 17-OHP and IRT.

Trial Details

FieldValue
Enrollment Target 7,462 participants
Start Date 2011-12
Est. Completion 2012-04

Sponsor

Luminex Corporation

5 total trials

What the Registry Record Tells You About NCT01488721

The ClinicalTrials.gov registry entry for NCT01488721 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,462 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Luminex Corporation, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01488721 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01488721 about?

NCT01488721 is a clinical study titled "Clinical Evaluation of NeoPlex4 Assay and NeoPlex System". The purpose of this study is to assess the agreement of clinical performance between the proposed NeoPlex 4 assay and NeoPlex System and the comparator devices in clinical use in newborn screening programs for detection of T4, TSH, 17-OHP and IRT.

What is the current status of trial NCT01488721?

This trial is currently completed. The enrollment target is 7,462 participants. The study started on 2011-12. Estimated completion is 2012-04.

Who is sponsoring clinical trial NCT01488721?

This trial is sponsored by Luminex Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.